Keywords: gw, sativex, filed, ms, spasticity, europe, uk

GW's Sativex filed for MS spasticity in Europe

Article | 11 September 2006

Print This

The UK's GW Pharmaceuticals has filed a regulatory submission in certain European countries for Sativex, its cannabinoid spray medicine, for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in